Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sang Hun | - |
dc.contributor.author | Jeong, Dongjun | - |
dc.contributor.author | Han, Yong-Seok | - |
dc.contributor.author | Baek, Moo Jun | - |
dc.date.accessioned | 2021-08-11T20:24:00Z | - |
dc.date.available | 2021-08-11T20:24:00Z | - |
dc.date.issued | 2015-07 | - |
dc.identifier.issn | 2288-6575 | - |
dc.identifier.issn | 2288-6796 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/10540 | - |
dc.description.abstract | The shaping of new blood vessels is a significant event in cancer growth and metastasis. Therefore, the molecular system of cancer angiogenesis has garnered considerable interest in cancer research. The vascular endothelial growth factor (VEGF) and VEGF receptor pathway are recognized as the key regulators of the angiogenic process. Activation of the VEGF/VEGF-receptor pathway initiates signaling cascades that promote endothelial cell growth, migration, and differentiation. Recently, VEGF was shown to play a role in the recruitment of bone marrow-derived endothelial progenitor cells to neovascularization sites. The role of VEGF in promoting tumor angiogenesis and the occurrence of human cancers has led to the rational design and development of agents that selectively target this pathway. Moreover, these anti-VEGFNEGF receptor agents show therapeutic potential by inhibition of angiogenesis and tumor growth in preclinical models. In this review, we summarize the role of the VEGF pathway during tumor angiogenesis. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한외과학회 | - |
dc.title | Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4174/astr.2015.89.1.1 | - |
dc.identifier.scopusid | 2-s2.0-84981747169 | - |
dc.identifier.wosid | 000357238400001 | - |
dc.identifier.bibliographicCitation | 대한외과학회지, v.89, no.1, pp 1 - 8 | - |
dc.citation.title | 대한외과학회지 | - |
dc.citation.volume | 89 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 8 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART001999668 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | HYPOXIA-INDUCIBLE FACTORS | - |
dc.subject.keywordPlus | FACTOR GENE-EXPRESSION | - |
dc.subject.keywordPlus | ANTI-VEGF TREATMENT | - |
dc.subject.keywordPlus | FACTOR-C | - |
dc.subject.keywordPlus | INHIBITS ANGIOGENESIS | - |
dc.subject.keywordPlus | MONOCLONAL-ANTIBODY | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.subject.keywordPlus | CYCLOOXYGENASE-2 | - |
dc.subject.keywordAuthor | Angiogenesis inhibitors | - |
dc.subject.keywordAuthor | Vascular endothelial growth factor receptors | - |
dc.subject.keywordAuthor | Cell hypoxia | - |
dc.subject.keywordAuthor | Tumor microenvironment | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.